Here we performed the largest GWAS to identify novel genetic factors affecting plasma ApoE level as well as to test if baseline plasma ApoE level affects cognitive function and incident dementia in a longitudinal cohort of the Ginkgo Evaluation of Memory (GEM) study [17–19]. The gene discussed is APOE; the disease is dementia.